Joseph Mattingly, MD
Emergency Medicine · Brownsville, TXNPI 1285042481
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $40,000 of the $41,089 with a category attached, or 97.3%. AbbVie accounts for 99.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $25,381 and has fallen 98.7% since, to $340 in 2024. Among emergency medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $1369.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$41K
- Inari Medical, Inc.$107
- Revance Therapeutics, Inc.$93
- Merz North America, Inc.$76
- Galderma Laboratories, L.p.$33
What the payments were for
- Speaking & faculty fees$40,00097%
- Food & beverage$1,0893%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $40,780 |
| Inari Medical, Inc. | 1 | $107 |
| Revance Therapeutics, Inc. | 1 | $93 |
| Merz North America, Inc. | 2 | $76 |
| Galderma Laboratories, L.p. | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,089 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $391 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $222 |
| Ibuprofen | 40 | $134 |
| Ondansetron OdtOndansetron | 18 | $131 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 18 | $62 |
| Azithromycin | 11 | $52 |
| Levofloxacin | 12 | $37 |
| Prednisone | 16 | $34 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Brownsville
- John McKinneyTyler$1.9M
- William PeacockHouston$513K
- Myiesha TaylorSunnyvale$369K
- James WilliamsSan Antonio$360K
- Armando MolinaEl Paso$290K
- Arthur AbelloAustin$204K
- Farid DharamsiDallas$159K
- David RobinsonHouston$143K
- Basil KhalafHouston$93K
- Elizabeth FaganMcKinney$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.